Galectin Therapeutics (NASDAQ: GALT) announced that it has entered into securities purchase agreement with certain institutional investors providing for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE